Target product profiles for pan-Africa recombinant antivenoms against neurotoxic or hemotoxic and cytotoxic snakebite envenoming.
Saved in:
Main Authors: | Andreas H Laustsen, Melisa Benard-Valle, Abdulrazaq G Habib, Nicholas R Casewell, Michael Abouyannis, David G Lalloo, Anne Ljungars |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0012833 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
by: Sanjib Kumar Sharma, et al.
Published: (2019-01-01) -
Clinical Characteristics of Snakebite Envenomings in Taiwan
by: Yan-Chiao Mao, et al.
Published: (2024-12-01) -
Epidemiological and sociodemographic description of snakebite envenoming cases in Paraguay reported between 2015 and 2021
by: Guillermo Sequera, et al.
Published: (2024-04-01) -
From fangs to antidotes: A scoping review on snakebite burden, species, and antivenoms in the Eastern Mediterranean Region.
by: Ali Alshalah, et al.
Published: (2024-07-01) -
Physical and Sensory Long-Term Disabilities from <i>Bothrops</i> Snakebite Envenomings in Manaus, Western Brazilian Amazon
by: Eduardo M. G. Fernández, et al.
Published: (2025-01-01)